Publication

  • 85.

    Bourke C, Takashima E, Chan LJ, Dietrich MH, Mazhari R, White M, Sattabongkot J, Tham WH, Tsuboi T, Mueller I, Longley R.
    Comparison of total immunoglobulin G antibody responses to different protein fragments of Plasmodium vivax Reticulocyte binding protein 2b.
    Malar J. 2022 Mar 4;21(1):71. doi: 10.1186/s12936-022-04085-x.
    PMID: 35246142

  • 84.

    Miura K, Takashima E, Pham TP, Deng B, Zhou L, Huang WC, Diouf A, Gebremicale YT, Tachibana M, Ishino T, Richter King C, Lovell JF, Long CA, Tsuboi T.
    Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230.
    NPJ Vaccines. 2022 Jan 13;7(1):4. doi: 10.1038/s41541-021-00423-3.
    PMID: 35027567

  • 83.

    Morita M, Kanoi BN, Shinzawa N, Kubota R, Takeda H, Sawasaki T, Tsuboi T, Takashima E.
    AGIA Tag System for Ultrastructural Protein Localization Analysis in Blood-Stage Plasmodium falciparum.
    Front Cell Infect Microbiol. 2021 Dec 15;11:777291. doi: 10.3389/fcimb.2021.777291. eCollection 2021.
    PMID: 34976861

  • 82.

    Takashima E, Tachibana M, Morita M, Nagaoka H, Kanoi BN, Tsuboi T.
    Identification of Novel Malaria Transmission-Blocking Vaccine Candidates.
    Front Cell Infect Microbiol. 2021 Nov 30;11:805482. doi: 10.3389/fcimb.2021.805482. eCollection 2021.
    PMID: 34917521

  • 81.

    Tachibana M, Takashima E, Morita M, Sattabongkot J, Ishino T, Culleton R, Torii M, Tsuboi T.
    Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation.
    Parasitol Int. 2022 Apr;87:102525. doi: 10.1016/j.parint.2021.102525. Epub 2021 Dec 9.
    PMID: 34896614

  • 80.

    Rambhatla JS, Tonkin-Hill GQ, Takashima E, Tsuboi T, Noviyanti R, Trianty L, Sebayang BF, Lampah DA, Marfurt J, Price RN, Anstey NM, Papenfuss AT, Damelang T, Chung AW, Duffy MF, Rogerson SJ.
    Identifying Targets of Protective Antibodies against Severe Malaria in Papua, Indonesia, Using Locally Expressed Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1.
    Infect Immun. 2022 Feb 17;90(2):e0043521. doi: 10.1128/IAI.00435-21. Epub 2021 Dec 6.
    PMID: 34871039

  • 79.

    Muthui MK, Takashima E, Omondi BR, Kinya C, Muasya WI, Nagaoka H, Mwai KW, Orindi B, Wambua J, Bousema T, Drakeley C, Blagborough AM, Marsh K, Bejon P, Kapulu MC.
    Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes.
    Front Cell Infect Microbiol. 2021 Nov 12;11:774537. doi: 10.3389/fcimb.2021.774537. eCollection 2021.
    PMID: 34869075

  • 78.

    Chotirat S, Nekkab N, Kumpitak C, Hietanen J, White MT, Kiattibutr K, Sa-Angchai P, Brewster J, Schoffer K, Takashima E, Tsuboi T, Harbers M, Chitnis CE, Healer J, Tham WH, Nguitragool W, Mueller I, Sattabongkot J, Longley RJ. Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand. Front Microbiol. 2021 Jun 29;12:643501. doi: 10.3389/fmicb.2021.643501. eCollection 2021. PMID: 34276583

  • 77.

    Longley RJ, White MT, Brewster J, Liu ZSJ, Bourke C, Takashima E, Harbers M, Tham WH, Healer J, Chitnis CE, Monteiro W, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I. IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection. Open Forum Infect Dis. 2021 May 22;8(6):ofab228. doi: 10.1093/ofid/ofab228. eCollection 2021 Jun. PMID: 34159216

  • 76.

    Sasai M, Ma JS, Okamoto M, Nishino K, Nagaoka H, Takashima E, Pradipta A, Lee Y, Kosako H, Suh PG, Yamamoto M. Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells. J Exp Med. 2021 Jul 5;218(7):e20201763. doi: 10.1084/jem.20201763. Epub 2021 May 10. PMID: 33970189